林 宏樹

Medicine & Life Sciences

1. Dialysis 100%
2. Cohort Studies 90%
3. Japan 74%
4. Kidney 61%
5. Lipoid Nephrosis 46%
6. Acute Kidney Injury 46%
7. Nephrotic Syndrome 44%
8. Mortality 43%
9. Chronic Renal Insufficiency 41%
10. Prospective Studies 39%
11. Serum 33%
12. Lupus Nephritis 32%
13. Membranous Glomerulonephritis 31%
14. Biopsy 24%
15. Calcitriol Receptors 24%
16. Retrospective Studies 23%
17. Immunoglobulin A 22%
18. Creatinine 22%
19. Proteinuria 22%
20. Confidence Intervals 21%
21. Incidence 20%
22. Ascites 19%
23. Lipocalin-2 19%
24. Peroxidase 19%
25. Antineutrophil Cytoplasmic Antibodies 19%
26. Glomerular Filtration Rate 18%
27. Immunoglobulin G4-Related Disease 18%
28. Kidney Diseases 17%
29. Vasculitis 17%
30. Immunoglobulin G 17%
31. Uric Acid 16%
32. Focal Segmental Glomerulosclerosis 16%
33. Recurrence 15%
34. Chronic Kidney Failure 15%
35. Nephrology 15%
36. Immunosuppressive Agents 15%
37. Renin-Angiotensin System 15%
38. Albumins 15%
39. Aortic Valve Stenosis 14%
40. Therapeutics 14%
41. Hematinics 13%
42. Infections 13%
43. Moraxellaceae Infections 13%
44. Renal Dialysis 12%
45. Kidney Transplantation 12%
46. monoferrous acid citrate 12%
47. Practice Guidelines 12%
48. Phosphates 12%
49. Diabetic Nephropathies 11%
50. Epidural Neoplasms 11%